Shushrusha Heart Care Center & Speciality Hospital

Details Doctors
Medical Suppliers In Maharashtra

Name :

Shushrusha Heart Care Center & Speciality Hospital

Address  :

Plot No. 22A, Phase III
Plam Beach Road
Sector-6, Nerul

Town  :

Navi Mumbai

State  :

Maharashtra

Country  :

INDIA

Post Code:

400 706

Phone  :

022-39862112

Fax  :

91 22 27719247

Web URL  :

Available
Specialization
  • Anaesthesiology
  • Angiography.
  • Cardiology
  • Cardiothoracic Surgeon
  • CT Scanning
  • Daibetes, Endocrinology
  • Neuro Surgeon
  • Neurologist
  • Orthopedics
  • Paediatrics
  • Pathology Lab
  • X-Ray
Facilities

Total Number Of Beds : 10

Speciality Type :

Super Speciality :

  • Neuro Surgical
  • Neprology
  • Neurology

Other Facilities

  • Pathology
  • X-Ray
  • CT/MRI
Description
Welcome to Shushrusha Heart Care Center amp Speciality Hospital
The Hospital takes honour of performing first Heart surgery and Heart Inasive proceduresAngiography Plasty Stenting in Navi Mumbai The Hospital has recently installed Spiral CT Scanner and MRI

Taking the above facts into consideration with a noble ambition Dr SR Tarlekar and Dr Mrs Anita S Tarlekar put in untiring efforts and conceptualized the existence of Shushrusha Heart Care Centre and Speciality Hospital a superspeciality cardiac care hospital in Navi Mumbai which caters to the medical needs of the residents of Navi Mumbai Raigad Thane and adjoining districts and provides them a healthy life
NEWS
Cancer Drugs Get Cheaper in India

Roche Holding AG is cutting the price of two expensive cancer drugs in India and giving them new names in an effort to gain market share and avoid competition from generic drugs in the fastgrowing economy The move marks a shift for the Swiss drug maker which long has argued that consumers everywhere should pay the same price for its medications By... Read More

ARTICLES
Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More